MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ OMX, has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants.
In spring 2013 Arcam and Disanto Technology Inc. entered into a strategic cooperation in order to make a joint development of customers for contract manufacturing of advanced orthopedics implants based on Arcam´s EBM technology. In connection with the cooperation DiSanto bought two EBM systems. With this new order DiSanto increases its EBM based production.
“The cooperation with DiSanto is developing very well and with this new order DiSanto increases its manufacturing capacity to meet the demand on EBM manufactured implants”, says Magnus René, CEO of Arcam.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB - Krokslätts Fabriker 27A - SE-431 37 Mölndal, Sweden - 46-31-710 32 00 - www.arcam.com
This information was brought to you by Cision http://news.cision.com